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The effect of combined treatment of alpha-tocopherol, ascorbic acid, and pyridoxine with
NMDA blocker memantine on penicillin-induced epileptiform activity in rats
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Aim: To evaluate the effects of coadministration of vitamins alpha-tocopherol, ascorbic acid, and pyridoxine with memantine on a
penicillin-induced experimental epilepsy model in rats so as to clarify the eventual interaction between these vitamins and the N-methylD-aspartate (NMDA) system.
Materials and methods: The epileptic focus was produced by intracortical penicillin G potassium injection. The effects of intraperitoneal
injections of memantine, memantine + alpha-tocopherol, memantine + ascorbic acid, and memantine + pyridoxine combinations on
epileptiform activity were evaluated in electrocorticogram recordings.
Results: The antiepileptiform effects appeared earlier in all memantine and vitamin coadministrated groups compared to the
memantine-alone group, but the difference between the groups was not statistically significant considering the frequency and amplitude
of the epileptiform activity.
Conclusion: Coadministration of vitamins does not enhance the antiepileptiform activity of memantine in penicillin-induced epilepsy
in rats. However, this coadministration causes the earlier appearance of antiseizure effects. Since moderate doses of these vitamins have
no side effects, it might be a good idea to use them with NMDA blockers to provide an earlier antiepileptic effect.
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1. Introduction
Epileptogenesis is associated with an imbalance between
excitatory and inhibitory control systems in selective
regions of the brain. Particularly, excessive activation of
N-methyl-D-aspartate (NMDA)-type glutamate receptors,
manifested as neuronal excitotoxicity, has been linked
to several neurological disorders including epilepsy (1).
The therapeutic potential of various NMDA antagonists
has been investigated in different experimental models of
epilepsy (1,2), but none have proven to be both effective and
safe. Memantine is a low-affinity, uncompetitive antagonist
on NMDA receptors. It is approved for treatment of
Alzheimer disease and now has potentially wide-ranging
applications, from neuroprotection to the treatment of
experimental epilepsy, without the undesirable side effects
of many high-affinity NMDA receptor antagonists (3).
On the other hand, it was reported that free radicals
could inactivate glutamine synthase and could induce
epileptic seizures by abnormal expression of the excitatory
neurotransmitter, glutamic acid (4). The biological
* Correspondence: drduygucakil@hotmail.com

effects of free radicals are controlled by a wide range of
antioxidants, such as ascorbic acid, alpha-tocopherol,
and pyridoxine (5–7). It has also been suggested that
such vitamins have neuroprotective properties in some
experimental models of epilepsy (7–11). Alpha-tocopherol
protects cell membranes against oxidative damage by
regulating the production of reactive oxygen species
(ROS) and maintaining oxidative phosphorylation in
mitochondria, thus accelerating the regeneration of high
energy phosphates (6), whereas ascorbic acid scavenges
the aqueous ROS by very rapid electron transfer and
thus inhibits lipid peroxidation (5). Ascorbate has also
been suggested to decrease NMDA-mediated currents by
acting at the redox modulatory site of the NMDA receptor.
Pyridoxine is the active coenzyme for many enzymes,
including glutamic acid decarboxylase, an enzyme that has
a role in gamma-aminobutyric acid (GABA) synthesis in
mammalian cells (12). GABA is a neurotransmitter with
an important role in the pathophysiology and treatment
of epilepsy.
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Therefore, we can say that all 3 vitamins chosen for this
study are related to 1 or more antiepileptogenic pathways.
However, to our knowledge, no published data are available
about the effects of these vitamins on the antiepileptic
potential of any drugs in experimental models of epilepsy.
Consequently, the objectives of the present study were
to comparatively study the effects of coadministration of
memantine with ascorbic acid, pyridoxine, and alphatocopherol on penicillin-induced epileptiform activity in
rats in order to clarify their interaction with the NMDA
system.
2. Materials and methods
2.1. Subjects
Adult male Wistar rats weighing 200–250 g were used
throughout this study. All described procedures were
approved by the local ethics committee. The animals were
housed in standard cages and were allowed free access to
food and water. They were kept in a temperature-controlled
(22 ± 1 °C) environment on a 12-h light/dark cycle.
2.2. Experimental groups
The rats were assigned to the following experimental
groups and each group comprised 7 rats:
(1) Penicillin (500 IU, 2.5 µL, intracortical);
(2) Penicillin + memantine (5 mg/kg, intraperitoneal
[i.p.]);
(3) Penicillin + memantine + pyridoxine (40 mg/kg,
i.p.);
(4) Penicillin + memantine + alpha-tocopherol (500
mg/kg, i.p.);
(5) Penicillin + memantine + ascorbic acid (100 mg/
kg, i.p.)
2.3. Surgical procedure
The animals were anesthetized with a single injection of
urethane (1.25 g/kg, i.p.) and placed in a stereotaxic frame.
Rectal temperature was maintained between 36–37 °C
using a feedback-controlled heating system. A polyethylene
cannula was introduced into the right femoral artery
to monitor blood pressure, which was kept above 110
mmHg during the experiments (mean: 120 ± 5 mmHg).
The left cerebral cortex was exposed by craniotomy (5 mm
posterior to bregma and 3 mm lateral to sagittal sutures).
Two Ag-AgCl ball electrodes were placed over the left
somatomotor cortex (electrode coordinates: first electrode
2 mm lateral to sagittal suture and 1 mm anterior to
bregma, second electrode 2 mm lateral to sagittal suture
and 5 mm posterior to bregma). The common reference
electrode was fixed on the pinna.
2.4. Drug and drug administration
The epileptic focus was produced by 500 IU of intracortical
penicillin G potassium injection (short-term experimental
model of focal epilepsy; 1 mm beneath the brain surface by
a Hamilton microsyringe, type 701N (Aldrich, Milwaukee,
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WI, USA), infusion rate 0.5 µL/min) (9). Memantine was
dissolved in distilled water and administrated 30 min
after the penicillin injection (5 mg/kg, i.p.). Ascorbic
acid, alpha-tocopherol, or pyridoxine were administrated
intraperitoneally 15 min after the memantine injection.
2.5. Electrocorticography recordings
The electrocorticography (ECoG) activity was
continuously monitored on a recorder (PowerLab, 4/SP,
AD Instruments, Castle Hill, Australia) and was stored
on a computer. The frequency and amplitude of the
epileptiform ECoG activities were analyzed offline.
2.6. Data analysis
All statistical procedures were performed using SPSS 12.0.
The differences between the groups were analyzed with
one-way ANOVA. Significant differences were further
evaluated using the Tamhane post hoc test. Data were
expressed as mean ± standard error of the mean (SEM).
Statistical significance was set at P < 0.05.
3. Results
The epileptiform activity characterized by spikes and
spike–wave complexes began 2–5 min after the penicillin
injection, reached a constant level of frequency and
amplitude in 30 min, and lasted for 3–5 h (Figure 1). We
used the most effective doses of memantine (5 mg/kg, i.p.)
(9), ascorbic acid (100 mg/kg, i.p.) (2), alpha-tocopherol
(500 mg/kg, i.p.) (3), and pyridoxine (40 mg/kg, i.p.) (7)
for penicillin-induced epileptiform activity, which were all
determined in previous studies. Memantine significantly
decreased the frequency of epileptiform activity 50 min
after injection (Figure 2). The mean spike frequency of
ECoG activity was 14 ± 2 spikes/min in the memantineadministrated group at 60 min after injection. Significant
anticonvulsant effects were seen at 40 min, 40 min, and 30
min after memantine injection in the groups administered
memantine + ascorbic acid, memantine + alpha-tocopherol,
and memantine + pyridoxine, respectively (Figure 2). The
mean spike frequencies of epileptiform activities were 13 ±
3, 13 ± 3, and 12 ± 2 spikes/min at 60 min after memantine
injection in the memantine + ascorbic acid, memantine +
alpha-tocopherol, and memantine + pyridoxine groups,
respectively. The earliest antiepileptiform effect appeared
in the memantine + pyridoxine group as compared to the
other groups. No significant difference was found regarding
the mean spike amplitude of epileptiform activity in any of
the groups (Figure 3). The mean spike amplitudes of ECoG
activities were 783 ± 50 µV, 1014 ± 146 µV, and 1000 ± 258
µV in the memantine + ascorbic acid, memantine + alphatocopherol, and memantine + pyridoxine groups 60 min
after the memantine injection, respectively.
4. Discussion
Previous experiments have shown that memantine,
pyridoxine, alpha-tocopherol, and ascorbic acid have
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A) Baseline activity

500 μV
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1000 μV
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B) Control (Penicillin G)

C) Memantine

D) Memantine + Ascorbic acid

E) Memantine + Pyridoxine

F) Memantine + Alpha-tocopherol

Figure 1. A) The baseline ECoG activities. B) Penicillin (500
IU)-induced epileptiform ECoG activity characterized by spikes
and spike-wave complexes. ECoG activities of C) memantine,
D) memantine + ascorbic acid, E) memantine + pyridoxine, and
F) memantine + alpha-tocopherol at 40 min after memantine
injection. Antiepileptogenic activity of memantine has not begun,
but we can see decreased spike frequencies in all memantine +
vitamin groups.

anticonvulsive effects on penicillin-induced epileptic
activity in rats (3,8–10). In this study, we investigated
for the first time the effects of coadministration of the
NMDA receptor antagonist memantine with pyridoxine,
alpha-tocopherol, and ascorbic acid on penicillin-induced
epileptiform activity in order to clarify the eventual

relationship between the antiepileptiform effects of these
vitamins and the NMDA system.
Penicillin injection to the somatomotor cortex is a
widely used method for inducing epileptiform activity
in rats. In the anesthetized animal, this activity is
characterized by the focal interictal epileptiform discharges
(13). Penicillin was reported to increase the excitability of
presynaptic nerve terminals and to enhance the excitatory
effects of glutamate on the brain (14).
Glutamate is the major excitatory neurotransmitter in the
central nervous system. Excessive activation of the NMDA
subtype of glutamate receptors causes hyperexcitation
neurotoxicity, which is involved in the pathophysiology
of neurological disorders including epilepsy. Memantine
is an uncompetitive voltage-dependent NMDA receptor
antagonist that preserves the normal function of the receptor
but protects the brain from NMDA receptor-mediated
excitotoxicity. Memantine has potential antiepileptic effects
in some experimental models of epilepsy, such as seizures
induced by picrotoxin, bicuculline, 3-mercaptopropionic
acid (15), and pentylenetetrazol (16) in the absence of
serious side effects, suggesting that it might have potential
efficiency in the treatment of epileptic seizures. In our
previous study we used 5 different doses of memantine (1,
2.5, 5, 10, and 20 mg/kg) on penicillin-induced epilepsy,
and we showed that memantine decreased the mean
frequency of epileptiform activity at doses of 2.5 and
5 mg/kg (i.p.), with a maximal effect at 5 mg/kg without
changing the amplitude (3). Thus, in this study, we used the
most effective antiepileptogenic dose of memantine (5 mg/
kg) on penicillin-induced epilepsy. However, the present
study and most of the research in this field indicate that
memantine alone is not able to prevent epileptic activity.
Therefore, it would be a good idea to use combinations
of memantine with other potential antiepileptogenic
agents to obtain stronger antiseizure activity. For this
purpose, we chose 3 vitamins with different mechanisms
of action but similar potential antiepileptogenic effects.
The first vitamin, pyridoxine (vitamin B6), is an essential
nutrient for normal function of multiple organ systems
and a precursor of the cofactors, pyridoxal-5-phosphate
and pyridoxamine-5-phosphate, that form the active
site of many essential enzymes in human tissues (10,17).
Pyridoxine deficiency causes convulsions, particularly
in infants and also in experimental animals (18). The
antiepileptic effects of pyridoxine have also been studied in
different experimental epilepsy models. Bosnak et al. (10)
indicated that low-dose pyridoxine (40 mg/kg) significantly
reduced penicillin-induced epileptiform activity in rats.
Furthermore, the intravenous administration of pyridoxine
at 50–100 mg doses dramatically attenuated the clinical and
electrographic features of seizures (17). On the other hand,
high doses of this vitamin were shown to cause damage
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Figure 2. Effects of memantine (5 mg/kg, i.p.), memantine + ascorbic acid (100 mg/kg, i.p.), memantine + alpha-tocopherol (500
mg/kg, i.p.) and memantine + pyridoxine (40 mg/kg, i.p.) on the mean spike frequency of penicillin-induced epileptiform activity
in rats. Memantine significantly decreased the frequency of epileptiform activity 50 min after injection. The significant effects of
memantine + ascorbic acid, memantine + alpha-tocopherol, and memantine + pyridoxine on spike frequency were seen at 40 min,
40 min, and 30 min after memantine injection, respectively. All memantine + vitamin combinations showed earlier antiepileptic
effect compared to memantine applied alone (*P < 0.05, **P < 0.01, ***P < 0.001). The percentage frequency of epileptiform ECoG
activity value depends on both the frequency of epileptiform ECoG activity before and after the substance administered and is
defined as: frequency value (%) = (the mean of spike frequency after substance administered / the mean of spike frequency before
substance administered) × 100.

in the cerebral cortex in long-term treatment (19). The
second vitamin, alpha-tocopherol, was also shown to have
preventive effects on oxidative stress in animal studies (20).
Alpha-tocopherol was shown to have antiseizure activity
in several animal models, including ferrous chloride (21),
hyperbaric oxygen (22), kindling, pentylenetetrazol (23),
and penicillin (11) models. Kryzhanovskii et al. (24) showed
that penicillin-induced epileptiform activity increased the
lipoperoxidation product levels in the crude synaptosomal
fraction from the hyperactive focus, and alpha-tocopherol
abolished the effects of lipoperoxidation products and
decreased the seizure frequency on ECoG recordings. It
was also shown that alpha-tocopherol protects cells from
glutamate-induced toxicity by direct antioxidant action
in immature primary cortical neuron cultures (25). The
third vitamin, ascorbic acid, is highly concentrated in the
brain, and the release of ascorbic acid from brain cells is
associated with the glutamatergic neuron activity by the
glutamate–ascorbate heteroexchange across the neuronal
or glial cell membranes (26). This heteroexchange might
protect neurons by facilitating glutamate uptake in glial cell
membranes. On the other hand, ascorbic acid was shown
to have antioxidant properties in various experiments.
It was reported to reduce lipid peroxidation induced
by fenthion in rat tissues (27) and also to significantly
prevent 3-nitrotyrosine, a marker of oxidant peroxynitrite
formation in guinea pigs (28). Oliveira et al. (29) found
that a high dose of ascorbic acid (300 mg/kg) protected
rat brain against pentylenetetrazol-induced seizures. They
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also reported that at intermediate doses, it potentiated
the duration of convulsive episodes. Yamamoto et al. (30)
also showed that ascorbate pretreatment (200 mg/kg) 60
min before the induction of epileptic activity prevented or
delayed the occurrence of epileptic discharges in the ferrous
chloride model of experimental epilepsy. In penicillininduced epilepsy, ascorbic acid decreased the frequency of
the epileptiform activity at doses of 50–400 mg/kg (i.p.);
moreover, the occurrence of epileptiform activity was
delayed in the ascorbic acid-pretreated group (100 mg/kg,
i.p.) (8).
Additionally, the combination of anticonvulsant drugs
and vitamins may provide enhanced protection against
several diseases (31–34). Pretreatment with ascorbic acid
just prior to valproic acid (VPA) exposure prevents VPAinduced down regulation of the Hoxa2 gene expression
in concert with enhanced glutathione status, indicating a
protective effect on embryos (34). Vitamin C and vitamin
E were shown to enhance the catalepsy induced by nitric
oxide synthase inhibitors in mice (33) and also decrease the
oxidative stress produced by cell phores in rats (35). Chronic
administration of ascorbic acid combined with phenytoin
augments the resistance to urethane-induced loss of
righting reflex in experimental animals (32). Moreover, the
combination of memantine with vitamin D may enhance
the protection against Alzheimer disease (31).
In agreement with previous studies, the results of the
present study indicate that coadministration of memantine
with pyridoxine, alpha-tocopherol, and ascorbic
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Figure 3. The effects of memantine (5 mg/kg, i.p.), memantine + ascorbic acid (100 mg/kg, i.p.), memantine + alpha-tocopherol (500
mg/kg, i.p.), and memantine + pyridoxine (40 mg/kg, i.p.) on the mean spike amplitude of penicillin-induced epileptiform activity
in rats. There were no significant differences in the mean spike amplitude of any experimental groups. The percentage amplitude
of epileptiform ECoG activity value depends on both the amplitude of epileptiform ECoG activity before and after the substance
administered and is defined as: amplitude value (%) = (the mean of spike amplitude after substance administered / the mean of spike
amplitude before substance administered) × 100.

acid significantly decreased the penicillin-induced
epileptiform activity in the 30, 40, and 40 min after the
memantine injection, respectively. Since the antiepileptic
effects of pyridoxine, alpha-tocopherol, ascorbic acid,
and memantine on penicillin-induced epilepsy appeared
at 40, 60, 30, and 50 min after injection, respectively
(3,8–10), it can be concluded that all memantine +
vitamin combinations showed earlier antiepileptic effects
compared to memantine applied alone. Furthermore, in
our previous study, coadministration of memantine with
alpha-tocopherol and pyridoxine, but not with ascorbic
acid, showed earlier antiepileptic effects compared to
the vitamins applied alone (3). The antiepileptic effect of
memantine + ascorbic acid appeared earlier than it did
when memantine was applied alone, but later than when
ascorbic acid was applied alone. Unfortunately, we did
not have the chance to compare these results with others,

since no data are available on the effects of the combined
treatment of alpha-tocopherol, ascorbic acid, and
pyridoxine with the NMDA blocker memantine on other
experimental models of epilepsy. These results give rise to
the thought that an interaction might exist between the
antiepileptogenic effects of vitamins and NMDA system
on penicillin-induced epilepsy.
The present study demonstrates that coadministration
of memantine with effective doses of pyridoxine, ascorbic
acid, and alpha-tocopherol can cause earlier antiepileptic
effects on penicillin-induced epilepsy in rats compared
with memantine alone. However, it is important to
note that the results of the present study do not explain
the pathways these drug combinations use to suppress
epileptiform activity. Therefore, the eventual relationship
between these vitamins and the NMDA system must be
clarified with further electrophysiological investigations.
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